Stay updated on Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T18:59:41.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to include new information about the drug sacituzumab govitecan for metastatic breast cancer, including a new EudraCT number and a recent study citation, while significant details about the study's objectives and inclusion/exclusion criteria have been removed.
    Difference
    8%
    Check dated 2025-04-16T13:06:02.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T06:40:50.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T22:44:30.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.7%
    Check dated 2025-02-24T20:15:43.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.7%
    Check dated 2025-02-10T09:32:16.000Z thumbnail image

Stay in the know with updates to Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab vs Chemo in HR+/HER2- Metastatic Breast Cancer Clinical Trial page.